Antinociceptive effects of cocaine in rhesus monkeys

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 2, 1999, Pages 291-297

  Gatch, Michael B ^a   Negus, S Stevens ^a   Mello, Nancy K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antinociception; Cocaine; Macaca mulatta; Mianserin; Morphine; Opioids; Serotonin receptors

Indexed keywords

COCAINE; MIANSERIN; MORPHINE; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; COCAINE; DRUG INTERACTIONS; FEMALE; MACACA MULATTA; MALE; MIANSERIN; MORPHINE; PAIN MEASUREMENT; SEROTONIN ANTAGONISTS;

MACACA MULATTA; PRIMATES;

EID: 0032908614     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00163-4     Document Type: Article

References (48)

1. Ardid D., Eschalier A., Lavarenne J. Evidence for a central but not a peripheral analgesic effect of clomipramine in rats. Pain. 45:1991;95-100.
2. 5 (DAMGO) and morphine-induced antinociception in mice. J. Pharmacol. Exp. Ther. 256:1991;890-896.
3. 3H-norepinephrine from isolated brain tissue. J. Pharmacol. Exp. Ther. 189:1974;110-117.
4. Basbaum A.I., ;Fields H.L. Endogenous pain control systems. Brainstem spinal pathways and endorphin circuitry Annu. Rev. Neurosci. 7:1984;309-338.
5. Coda B.A., Hill H.F., Schaffer R.L., Luger T.J., Jacobson R.C., Chapman C.R. Enhancement of morphine analgesia by fenfluramine in subjects receiving tailored opioid infusions. Pain. 52:1993;85-91.
6. Cunningham K.A., Callahan P.M. Neurobehavioural pharmacology of cocaine. Role for serotonin in its locomotor and discriminative stimulus effects Erinott L., Brown R.M. NIDA research monograph 145. Neurobiological models for evaluating mechanisms underlying cocaine addiction:1994;40-66 U.S. Department of Health and Human Services, Government Printing Office, Washington, DC.
7. Dewey W.L., Harris L.S., Howes J.F., Nuite J.A. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J. Pharmacol. Exp. Ther. 175:1970;435-442.
8. Fitzgerald M. Monoamines and descending control of nociception. Trends Neurosci. 9:1986;51-52.
9. Foltin R.W., Christiansen I., Levin F.R., Fischman M.W. Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. J. Pharmacol. Exp. Ther. 275:1995;38-47.
10. Friedman E., Gershon S., Rotrosen J. Effects of acute cocaine treatment on the turnover of 5-hydroxytryptamine in the rat brain. Br. J. Pharmacol. 54:1975;61-64.
11. Frussa-Filho R., Rocha J., Conceição I., Mello C., Pereira M. Effects of dopaminergic agents on visceral pain measured by the mouse writhing test. Arch. Int. Pharmacodyn. Ther. 331:1996;74-93.
12. Gatch M., Negus S., Mello N. Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Psychopharmacology (Berlin). 135:1998;99-106.
13. Gatch M.B., Negus S.S., Butelman E.R., Mello N.K. Antinociceptive effects of cocaine/opioid combinations in rhesus monkeys. J. Pharmacol. Exp. Ther. 275:1995;1346-1354.
14. 3H)dopamine in rat brain tissue slices. Biochem. Pharmacol. 24:1975;847-852.
15. Hemby S.E., Jones G.H., Hubert G.W., Neill D.B., Justice J.B. Jr. Assessment of the relative contribution of peripheral and central components in cocaine place preference. Pharmacol. Biochem. Behav. 47:1994;973-979.
16. Howell L., Byrd L. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J. Pharmacol. Exp. Ther. 275:1995;1551-1559.
17. Hubbell C., Marglin S., Spitalnic S., Abelson M., Wild K., Reid L. Opioidergic, serotonergic, and dopaminergic manipulations and rat's intake of a sweetened alcoholic beverage. Alcohol. 8:1991;355-367.
18. Hynes M.D., Lochner M.A., Bemis K.G., Hymson D.L. Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptors. Life Sci. 36:1985;2317-2323.
19. Jaffe J.H., Martin W.R. Opioid analgesics and antagonists. Gilman A.G., Goodman L.S., Nies A.S., Taylor P. The pharmacological basis of therapeutics. 8:1990;485-521 Pergamon Press, New York.
20. Katz J.L., Tirelli E., Witkin J.M. Stereoselective effects of cocaine. Behav. Pharmacol. 1:1990;347-353.
21. Kaupilla T., Mercke E., Pertovaara A. Enhancement of morphine-induced analgesia and attenuation of morphine induced side-effects by cocaine in rats. Pharmacol. Toxicol. 71:1992;173-178.
22. Kiritsy-Roy J.S., Shyu B.C., Danneman P.J., Morrow T.J., Belczynski C., Casey K.L. Spinal antinociception mediated by a cocaine-sensitive dopaminergic supraspinal mechanism. Brain Res. 644:1994;109-116.
23. Kosten T.R., Gawin F.H., Rounsaville B.J., Kleber H.D. Cocaine abuse among opioid addicts. Demographic factors in treatment Am. J. Drug Alcohol Abuse. 12:1986;1-16.
24. Kosten T.R., Rounsaville B.J., Gawin F.H., Kleber H.D., Larson A.A., Takemori A.E. A 2.5 year follow-up of cocaine use among treated opioid addicts. Arch. Gen. Psychiatry. 44:1987;281-284.
25. Lamas X., Negus S.S., Hall E., Mello N.K. Relationship between the discriminative stimulus effects and plasma concentration of intramuscular cocaine in rhesus monkeys. Psychopharmacology (Berlin). 121:1995;331-338.
26. Larson A.A., Takemori A.E. Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance. Life Sci. 21:1977;1807-1812.
27. Lin Y., Morrow T.J., Kiritsy-Roy J.A., Terry L.C., Casey K.L. Cocaine. Evidence for supraspinal, dopamine-mediated, non-opiate analgesia Brain Res. 479:1989;306-312.
28. Lord J.A.H., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides. Multiple agonists and receptors Nature. 267:1977;495-499.
29. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine-dependent dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
30. Mello N.K., Negus S.S., Lukas S.E., Mendelson J.H., Sholar J.W., Drieze J. A primate model of polydrug abuse. Cocaine and heroin combinations J. Pharmacol. Exp. Ther. 274:1995;1325-1337.
31. Melzack R., Ofiesh J.G., Mount B.M. The Brompton mixture. Effects on pain in cancer patients Can. Med. Assoc. J. 115:1976;125-129.
32. Misra A.L., Pontani R.B., Vadlamani N.L. Stereospecific potentiation of opioid analgesia by cocaine. Predominant role of noradrenaline Pain. 28:1987;129-138.
33. Mount B., Ajemian I., Scott J. Use of the Brompton mixture in treating the chronic pain of malignant disease. Can. Med. Assoc. J. 115:1976;112-124.
34. Negus S., Gatch M., Mello N. Effects of mu opioid agonists alone and in combination with cocaine and d-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology. 18:1998;325-338.
35. 2-induced thermal hyperalgesia and its reversal by morphine in the warn-water tail-withdrawal procedure in rhesus monkeys. J. Pharmacol. Exp. Ther. 266:1993;1355-1363.
36. Nott M.W. Potentiation of morphine analgesia by cocaine in mice. Eur. J. Pharmacol. 5:1968;93-99.
37. Preston K.L., Sullivan J.T., Strain E.C., Bigelow G.E. Enhanced cocaine effects during methadone maintenance. NIDA Res. Monogr. 132:1993;337.
38. Schama K., Howell L., Byrd L. Serotonergic modulation of the discriminative stimulus effects of cocaine in squirrel monkeys. Psychopharmacology (Berlin). 132:1997;27-34.
39. Shimada A., Tsuda T., Yanagita T. Mode of potentiating action of cocaine in morphine analgesia. J. J. Pharmacol. 48:1988;185-193.
40. Shriver D.A., Long J.P. A pharmacological comparison of some quaternary derivatives of cocaine. Arch. Int. Pharmacodyn. Ther. 189:1971;198-208.
41. Sierra V., Duttaroy A., Lutfy K., Candido J., Billings B., Zito S.W., Yoburn B.C. Potentiation of opioid analgesia by cocaine. The role of spinal and supraspinal receptors Life Sci. 50:1992;591-597.
42. Spealman R.D. Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology (Berlin). 112:1993;93-99.
43. Terry P., Witkin J.M., Katz J.L. Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J. Pharmacol. Exp. Ther. 270:1994;1041-1048.
44. Tutton C.S., Crayton J.W. Current pharmacotherapies for cocaine abuse. A review J. Addict. Dis. 12:1993;109-127.
45. Ventafridda V., Bianchi M., Ripamonti C., Sacerdote P., DeCono F., Zecca E., Panerai A.E. Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man. Pain. 43:1990;155-162.
46. Witkin J.M., Nichols D.E., Terry P., Katz J.L. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J. Pharmacol. Exp. Ther. 257:1991;706-713.
47. Xu W., Qiu X.C., Han J.S. Serotonin receptor subtypes in spinal antinociception in the rat. J. Pharmacol. Exp. Ther. 269:1994;1182-1189.
48. Yaksh T.L. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal grey. Brain Res. 160:1979;180-185.